1. Home
  2. PPTA vs IDYA Comparison

PPTA vs IDYA Comparison

Compare PPTA & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perpetua Resources Corp.

PPTA

Perpetua Resources Corp.

HOLD

Current Price

$25.92

Market Cap

2.9B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$35.18

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PPTA
IDYA
Founded
2011
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.9B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
PPTA
IDYA
Price
$25.92
$35.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$25.38
$49.18
AVG Volume (30 Days)
2.1M
981.7K
Earning Date
11-17-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$214,834,000.00
Revenue This Year
N/A
$2,662.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5377.66
52 Week Low
$7.81
$13.45
52 Week High
$31.65
$37.08

Technical Indicators

Market Signals
Indicator
PPTA
IDYA
Relative Strength Index (RSI) 50.69 56.05
Support Level $25.35 $33.11
Resistance Level $29.10 $34.45
Average True Range (ATR) 1.92 1.24
MACD -0.14 -0.01
Stochastic Oscillator 35.85 47.11

Price Performance

Historical Comparison
PPTA
IDYA

About PPTA Perpetua Resources Corp.

Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: